Source:http://linkedlifedata.com/resource/pubmed/id/18023403
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-12
|
pubmed:abstractText |
Phosphatidic acid phosphohydrolase (PAP) catalyzes the dephosphorylation of phosphatidic acid (PA) to diacylglycerol, the second messenger responsible for activation of protein kinase C. Despite the crucial role of PAP lipid signaling, there are no data on PAP signaling function in the human heart. Here we present a nonradioactive assay for the investigation of PAP activity in human myocardium using a fluorescent derivative of PA, 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphate (BODIPY-PA), as substrate in an in vitro PAP-catalyzed reaction. Unreacted BODIPY-PA was resolved from the PAP products by a binary gradient HPLC system and BODIPY-diacylglycerol was detected by fluorimetry. The reaction proceeded at a linear rate for up to 60 min and increased linearly with increasing amounts of cardiac protein in a range of 0.25 to 8.0 microg. This assay proved to be sensitive for accurate quantitation of total PAP activity, PAP-1 activity, and PAP-2 activity in human atrial tissue and right ventricular endomyocardial biopsies. Total PAP activity was approximately fourfold higher in ventricular myocardium than in atrial tissue. There was negligible PAP-1 activity in atrial myocardium compared with ventricular myocardium, indicating regional differences in activities and distribution pattern of PAP-1 and PAP-2 in the human heart.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1096-0309
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
374
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
291-7
|
pubmed:meshHeading |
pubmed-meshheading:18023403-Animals,
pubmed-meshheading:18023403-Cell Membrane,
pubmed-meshheading:18023403-Chromatography, High Pressure Liquid,
pubmed-meshheading:18023403-Fluorescence,
pubmed-meshheading:18023403-Heart Atria,
pubmed-meshheading:18023403-Heart Ventricles,
pubmed-meshheading:18023403-Humans,
pubmed-meshheading:18023403-Hydrolysis,
pubmed-meshheading:18023403-Male,
pubmed-meshheading:18023403-Membrane Proteins,
pubmed-meshheading:18023403-Myocardium,
pubmed-meshheading:18023403-Phosphatidate Phosphatase,
pubmed-meshheading:18023403-Rats,
pubmed-meshheading:18023403-Rats, Wistar,
pubmed-meshheading:18023403-Reproducibility of Results,
pubmed-meshheading:18023403-Sensitivity and Specificity,
pubmed-meshheading:18023403-Time Factors
|
pubmed:year |
2008
|
pubmed:articleTitle |
A HPLC-fluorescence detection method for determination of phosphatidic acid phosphohydrolase activity: application in human myocardium.
|
pubmed:affiliation |
Medizinische Klinik II, Universitätsklinikum Schleswig-Holstein, 23538 Lübeck, Germany. christof.burgdorf@uk-sh.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|